The global qPCR assay market is expected to grow during the forecast period due to increase intervention of the government with regards to funding for research and development activities coupled with rising R&D activities in proteomics and genomics along with advancement in technology. Growing approaches for new diagnostic tools and techniques, evaluation of benefits to patient outcome and developing genome profiling techniques are the drivers expected to fuel the market in recent years. qPCR allows quantification and amplification of a real time targeted DNA molecule. It requires small sample and provides higher sensitivity, efficiency, and accuracy than the conventional PCR.
On the basis of product, the market is segmented into qPCR consumables, qPCR instruments and qPCR services. On the basis of application the qPCR assay market is classified into drug discovery, drug development, diagnosis, research and others. qPCR technology is majorly used in various diagnostic and research applications such as quantification of nucleic acid standards, rare allele detection, viral load quantification, separation and enrichment of mixtures, low-fold copy number discrimination, and NGS libraries quantification.
Geographically, cosmetic implant market is studied with respect to four regions as North America, Europe, RoW and Asia Pacific. The increasing requirement of personalized healthcare genetic testing in various disease areas such as cancer and diabetes is expected to fuel the market. The U.S. coding guidelines have assigned codes to reimbursement policies and healthcare services. Increasing prevalence of cardiovascular disorders and genetic disorders coupled with the rising investments in proteomics and genomics is expected to drive the qPCR assay market in the North American region during the forecast period. Asia Pacific market is projected to grow rapidly due to the development of various new technologies by the research institutes of emerging economies such as India, Japan and China.
Some key players in this market are Affymetrix Inc., Cepheid, Qiagen, Abbott Laboratories, Agilent Technologies, Bio-Rad, Beckman Coulter Inc., Becton, Dickinson and Co., Sigma-Aldrich Corp, GE Healthcare, Life Technologies, and Roche. Two most commonly used methods for labeling and detecting PCR products are TaqMan Assay or fluorogenic 5’ nuclease chemistry and SYBR Chemistry Green dye chemistry by LifeTechnologies.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.